$5.10
+0.60 (+13.33%)
Open$4.65
Previous Close$4.50
Day High$5.20
Day Low$4.60
52W High$36.61
52W Low$22.98
Volume—
Avg Volume132.2K
Market Cap110.88M
P/E Ratio27.81
EPS$1.12
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+542.5% upside
Current
$5.10
$5.10
Target
$32.77
$32.77
$27.05
$32.77 avg
$46.02
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.36M | 16.49M | 13.84M |
| Net Income | -919,800 | -1,097,385 | -862,011 |
| Profit Margin | -5.6% | -6.7% | -6.2% |
| EBITDA | -1,433,447 | -1,263,705 | -1,141,891 |
| Free Cash Flow | -1,064,720 | -1,173,966 | -726,945 |
| Rev Growth | +3.8% | -10.0% | -5.2% |
| Debt/Equity | 1.22 | 1.29 | 1.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |